Automating drug discovery
<!-- START_ABSTRACT -->
<p>
Advances in areas such as microfluidics-assisted chemical synthesis and biological testing, as well as in artificial intelligence systems, are increasingly providing opportunities to introduce greater automation into the small-molecule drug discovery process. Schneider highlights approaches and technologies that seem poised to be implemented robustly by medicinal chemists in the near future and analyses the challenges for their more widespread application
</p>
<!-- END_ABSTRACT -->
<!-- START_TEMPLATE -->
<ul>
<li>
Source:
</li>
<li>
Tags:
</li>
</ul>
<!-- END_TEMPLATE -->
Backlinks
These are the other notes that link to this one.
Nothing links here, how did you reach this page then?
Comment
Share your thoughts on this note. Comments are not public, they are
messages sent directly to my inbox.
Aquiles Carattino
This note you are reading is part
of my digital garden. Follow the
links to learn more, and remember that these notes evolve over time. After all,
this website is not a
blog.